Paysign Q3 2020 Earnings Report
Key Takeaways
Paysign reported its third quarter 2020 financial results, acknowledging the ongoing impact of the pandemic on its business, particularly affecting clients in the pharma and plasma industries. The company remains optimistic about recovery and targets a return to year-over-year growth, contingent on the pandemic's effects. Paysign is well-capitalized and anticipates an upturn in the fourth quarter from new client programs.
The pandemic continues to significantly impact Paysign's business, particularly affecting clients in the pharma and plasma industries.
Paysign remains cautiously optimistic about the recovery of its clients and aims to return to year-over-year growth, depending on the pandemic's effects.
The company is well-capitalized and prepared to withstand ongoing pandemic-related impacts.
Paysign anticipates an additional upturn in the fourth quarter due to the onboarding of new client programs.
Paysign
Paysign
Forward Guidance
Paysign anticipates an upturn in the fourth quarter resulting from new client programs.